Free Trial

Merck & Co., Inc. (MRK) SEC Filings & 10K Form

Merck & Co., Inc. logo
$98.05 -1.47 (-1.48%)
(As of 12/20/2024 05:45 PM ET)

Recent Merck & Co., Inc. SEC Filings

DateFilerForm TypeView
11/22/2024
1:28 PM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:05 PM
Merck & Co., Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
3:09 PM
Evaxion Biotech A/S (Subject)
Merck & Co., Inc. (Filed by)
Form SC 13G/A
11/04/2024
9:05 AM
Merck & Co., Inc. (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
10/31/2024
5:44 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
1:06 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
1:10 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
1:16 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
11:20 AM
Guindo Chirfi (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
5:41 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
12:20 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
12:23 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
12:25 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
12:37 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
12:37 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
12:38 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/04/2024
1:55 PM
Merck & Co., Inc. (Issuer)
Rothman Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:59 PM
Merck & Co., Inc. (Issuer)
Warden Kathy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
2:00 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
2:02 PM
Merck & Co., Inc. (Issuer)
RUSSO PATRICIA F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:41 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:44 PM
BAKER DOUGLAS M JR (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:44 PM
Merck & Co., Inc. (Issuer)
THULIN INGE G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:32 PM
Mayo Stephen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:34 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:38 PM
Craig Pamela J. (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:15 PM
LAVIZZO-MOUREY RISA J (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
3:39 PM
Merck & Co., Inc. (Filer)
Form CERT
05/20/2024
5:28 AM
Merck & Co., Inc. (Filer)
MSD Netherlands Capital B.V. (Filer)
Form 424B5
05/15/2024
10:31 AM
Merck & Co., Inc. (Filer)
MSD Netherlands Capital B.V. (Filer)
Form POSASR
05/06/2024
3:29 PM
Merck & Co., Inc. (Subject)
MIZELL STEVEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:15 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:17 PM
Li Dean Y (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:19 PM
Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
5:41 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
3:05 PM
Merck & Co., Inc. (Filer)
Form 10-K/A
04/11/2024
3:08 PM
Merck & Co., Inc. (Filer)
Form DEF 14A
04/11/2024
3:10 PM
Merck & Co., Inc. (Filer)
Form DEFA14A
04/11/2024
3:12 PM
Merck & Co., Inc. (Filer)
Form ARS
04/08/2024
12:56 PM
Larson Betty D (Reporting)
Merck & Co., Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/01/2024
4:16 PM
Inspire Investing, LLC (Filed by)
Merck & Co., Inc. (Subject)
Form PX14A6G
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

03/29/2024
3:12 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:14 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:16 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:18 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:57 PM
Bowyer Research, Inc. (Filed by)
Merck & Co., Inc. (Subject)
Form PX14A6G
03/11/2024
2:27 PM
Harpoon Therapeutics, Inc. (Issuer)
Merck & Co., Inc. (Reporting)
MERCK SHARP & DOHME LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:24 PM
Davis Robert M (Reporting)
Merck & Co., Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:01 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:35 PM
Merck & Co., Inc. (Subject)
Oosthuizen Johannes Jacobus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
5:39 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
2:29 PM
Evaxion Biotech A/S (Subject)
Merck & Co., Inc. (Filed by)
Form SC 13G
01/17/2024
4:52 PM
Harpoon Therapeutics, Inc. (Issuer)
Merck & Co., Inc. (Reporting)
MERCK SHARP & DOHME LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:27 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:18 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:MRK) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners